Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.
about
Glucocerebrosidase is shaking up the synucleinopathiesLysosomal integral membrane protein-2: a new player in lysosome-related pathologyAmbroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cellsBioanalysis of eukaryotic organellesNiemann-Pick C disease gene mutations and age-related neurodegenerative disordersA Novel Functional Missense Mutation p.T219A in Type 1 Gaucher's Disease.Comprehensive functional characterization of murine infantile Batten disease including Parkinson-like behavior and dopaminergic markers.Niemann-Pick disease type C or Gaucher's disease type 3? A clinical conundrum.Lysosomal adaptation: how the lysosome responds to external cuesSystems-based analyses of brain regions functionally impacted in Parkinson's disease reveals underlying causal mechanismsGenetic and pathological links between Parkinson's disease and the lysosomal disorder Sanfilippo syndrome.Development of targeted therapies for Parkinson's disease and related synucleinopathiesThe pallidopyramidal syndromes: nosology, aetiology and pathogenesis.An overview on the correlation of neurological disorders with cardiovascular disease.Synthesis and Evaluation of Hybrid Structures Composed of Two Glucosylceramide Synthase Inhibitors.Gaucher-Associated Parkinsonism.Cognitive impairment and dementia in Parkinson's disease: clinical features, diagnosis, and management.Glucocerebrosidase mutations alter the endoplasmic reticulum and lysosomes in Lewy body disease.Glucocerebrosidase L444P mutation confers genetic risk for Parkinson's disease in central Chinaα-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models.Quality control gone wrong: mitochondria, lysosomal storage disorders and neurodegeneration.Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutationsAnimal models for Gaucher disease research.Glucocerebrosidase involvement in Parkinson disease and other synucleinopathies.Cerebrospinal fluid biomarkers in Parkinson disease.Sphingolipid lysosomal storage disorders.Genetic convergence of Parkinson's disease and lysosomal storage disorders.Endoplasmic reticulum and lysosomal Ca²⁺ stores are remodelled in GBA1-linked Parkinson disease patient fibroblasts.Membrane lipids as therapeutic targets for Parkinson's disease: a possible link between Lewy pathology and membrane lipids.Parkinson's disease: acid-glucocerebrosidase activity and alpha-synuclein clearance.The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease.Beyond Krabbe's disease: The potential contribution of galactosylceramidase deficiency to neuronal vulnerability in late-onset synucleinopathiesA lysosomal lair for a pathogenic protein pairPlasma oligomeric alpha-synuclein is associated with glucocerebrosidase activity in Gaucher disease.The Enigmatic Role of GBA2 in Controlling Locomotor Function.Neurodegenerative disorder with brain iron accumulation previously known as SENDA syndrome now genetically determined.Novel activity-based probes for broad-spectrum profiling of retaining β-exoglucosidases in situ and in vivo.Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease.iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis.Excessive burden of lysosomal storage disorder gene variants in Parkinson's disease.
P2860
Q24337392-280F4276-B647-4E0F-AFEE-661F41869368Q28305187-59D1C963-8409-4370-8AE9-1F0D71F9AAECQ28308084-66E99120-2D40-4E3B-ACB0-8406EDC85FD4Q28384122-97F9600D-003C-4469-8926-BCE26A8D46FFQ28538079-E8CCB412-03E7-469D-BFF4-E5EC5B91757FQ30387151-40548D42-4B21-4EB2-9FBA-9B04462DAD0BQ30405389-20E36E07-203C-4AF5-A7DB-341F99545645Q33627623-9331ECC6-4EAA-4324-8FB2-ABBB21DC0FADQ33653699-33B784A0-F5B8-43C9-842F-683AA5DCEA84Q34109658-F5DE5CC9-90FB-4E18-8E60-E44BC529D4D1Q34234597-3805241C-7507-44C8-B0AE-A9D1FF373AB1Q34238616-055B8467-B4E6-416D-923E-907D9D4E002AQ34336776-057E8D45-CA44-40C5-9E23-6F7124AC9707Q34800195-E00A3CCD-F634-44B8-8128-17FBF8ECCEA7Q35817623-245593FE-A737-49AF-BFB6-D028C21244E7Q35851610-3BFCEEBA-7C4A-41FA-89F0-4A9FEEC18EC9Q35988441-77CFE1C4-278D-491D-B1DE-9D05F76EDC79Q36389683-0E73DD57-D118-4CB9-B01C-F6CD04504991Q36513434-A9AE6341-958F-4825-B7BB-0B215558536FQ36607556-6406CDFF-0FD7-48C7-897D-9A1CB8CAD803Q37686264-E0479572-650D-424D-8EEA-507026521615Q37687866-0C24EEAD-8EFE-4DEF-B6CB-7020E3AE694DQ37939781-E51DDEA4-62BD-43CC-908B-F183BEA5EA6DQ38007465-7FD83305-4B38-4994-A958-3ECDF68F72C3Q38082586-28FBAC96-5902-49D3-9C42-1A372B2E38E5Q38217766-E401F454-4B8C-4905-9EC3-0C96772E80ABQ38237560-34F08EA4-D620-4E94-9356-7FDFFBE1A3C8Q38389995-E7FDB035-D5B4-4227-B2E5-45855FA4F6AAQ38648684-58513BD1-172B-480C-81AE-0F8A718B1412Q38727638-6F26065B-A645-46C1-AB21-5714EA4A1859Q39148146-526FF2EC-7F57-44DB-B747-A6F0D5AAFF3EQ41122206-6F8484F2-B8A2-400F-8446-940A33448E5BQ41436833-57652202-DD39-470E-B0A2-5C0C3D5FDBF8Q46730330-07B4D198-9613-429A-B6FF-3184530330F9Q47144233-45E0B806-3BFE-4167-A93C-2C4E38F978EEQ47979886-58850714-A030-4F8A-A1D8-9F599D2D1597Q48302580-3CF4E64C-8192-4B43-9177-EB9DD224651EQ48526137-95C151E2-1880-4E10-9177-DC8DFEC091D5Q48729780-E0FE6ADF-A6FC-499A-8C02-98C7990C2BD9Q50424585-54AE8192-8635-4A39-ABAE-BFFA0ACAA3BB
P2860
Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 May 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.
@en
Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.
@nl
type
label
Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.
@en
Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.
@nl
prefLabel
Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.
@en
Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.
@nl
P2093
P2860
P356
P1433
P1476
Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond.
@en
P2093
Alessandra Recchia
Annick Raas-Rothschild
Christoph Wiessner
Christophe Lo Bianco
Tamar Shachar
P2860
P304
P356
10.1002/MDS.23774
P407
P577
2011-05-26T00:00:00Z